Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT07260760
Eligibility Criteria:
Inclusion Criteria:
* 1: Age≥18
2: Acute ischemic stroke in the anterior circulation occurring within 48 hours
3: Baseline NIHSS score of 1-15 points (mild stroke: baseline NIHSS score of 1-5 points; moderate stroke: baseline NIHSS score of 6-15 points)
4: Pre-onset mRS score≤1
5: Use of Edaravone (injection or tablets)
6: Exclude intracranial hemorrhage
7: Sign the informed consent form
Exclusion Criteria:
* 1: A head CT or MRI scan indicates the presence of intracranial hemorrhagic disease
2: Patients with cerebral embolism or suspected cerebral embolism who also have severe atrioventricular block, atrial fibrillation, myocardial infarction, valvular heart disease, infective endocarditis, or a heart rate below 50 beats per minute
3: Abnormal liver function (ALT or AST transaminase levels exceeding the upper limit of normal), abnormal kidney function (creatinine levels exceeding the upper limit of normal), or individuals with other severe systemic diseases, etc
4: Allergy to the test drug
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07260760
Study Brief:
Protocol Section:
NCT07260760